Evolution of opioids reimbursement since 2004 from the national database of the general health insurance system

Therapie

Volumn 66, Issue 4, 2011, Pages 369-372

  Pauly, Vanessa ^a   Pradel, Vincent ^b,c   Frauger, Elisabeth ^b,c   Micallef, Joelle ^b,c   Thirion, Xavier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Drug utilization; Health insurance reimbursement; Opiate substitution treatment; Opioid analgesics; Substance related disorder

Indexed keywords

BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; DIHYDROCODEINE; FENTANYL; HYDROMORPHONE; METHADONE; OPIATE; TRAMADOL;

ANALGESIA; ARTICLE; DRUG DEPENDENCE TREATMENT; DRUG UTILIZATION; HEALTH CARE ACCESS; HUMAN; LOW DRUG DOSE; METHADONE TREATMENT; OPIATE ADDICTION; PAIN; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; REIMBURSEMENT;

EID: 80051990628     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2011037     Document Type: Article

References (20)

1. Circulaire DGS/DH N° 98/586 du 22 septembre 1998 relative à la mise en oeuvre du plan d'action triennal de lutte contre la douleur dans les établissements de santé publics et privés
2. Programme de lutte contre la douleur 2002-2005. Ministère de l'emploi et de la solidarité. Ministère délé gué à la santé
3. Plan d'amélioration de la prise en charge de la douleur 2006 - 2010. Ministère de la santé et des solidarités
4. Medic'AM 2004-2008 : les statistiques de la CNAMTS sur les medicaments remboursés. 2008-les-statistiques-de-la-cnamts-sur-les- medicamentsrembourses
5. WHO Collaborating Center For Drug Statistics Methodology (2010).Guidelines for ATC classification and DDD Assignment, 2010. Oslo, Norway
6. De Conno F, Ripamonti C, Brunelli C. Opioid purchases and expenditure in nine western European countries: 'Are we killing off morphine?' Palliat Med 2005; 19: 179-84
7. Garcia del Pozo J, Carvajal A, Maria Viloria J, et al. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol 2008; 64: 411-5
8. Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. European Journal of Pain 2009; 13: 954-62
9. Fredheim O, Skurtveit S, Breivik H, et al. Increasing use of opioids from 2004 to 2007- Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010; 14: 289-94
10. Bandieri E, Chiarolanza A, Luppi M, et al. Letters to the editor. Prescription of opioids in Italy: everything, but the morphine. Ann Oncol 2009; 20: 961-2
11. Afssaps. Retrait des médicaments contenant l'association dextropropoxyphène/ paracétamol (Di-Antalvicr® et ses génériques) ou dextropropoxyphène/ paracétamol/ caféine (Propofanr® et ses génériques).2010 Communiques-Points-presse/Medicaments-contenantdu- dextropropoxyphene-Retrait- progressif-de-l-AMMCommunique
12. Gaubert S, Vié M, Damase-Michel C, et al. Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption. Fundam Clin Pharmacol 2009; 23: 247-52
13. Castot A, Veyries M, Afssaps. Management of the withdrawal of medicines containing dextropropoxyphene (DXP) and paracetamol (P) from the French Market. Abstracts of the 15th Annual Meeting of the French Society of Pharmacology and Therapeutics, the 78th Annual Meeting of Society of Physiology, the 32th Pharmacovigilance Meeting, the 12th APNET Seminar and the 9th CHU IC Meeting. Fundam Clin Pharmacol 2011; 25 (Suppl 1): 492
14. International Narcotics Control Board; United Nations population data by: Pain & Policy Studies Group, University ofWisconsin/WHO Collaborating Center, 2010. morphinegraph.pdf
15. Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and non medical use of opioids: a ten-year perspective. Pain Physician 2010; 13: 401-35
16. The Newsmagazine for Pharmacists, 2009. Top 200 generic drugs by total prescriptions. data/articlestandard/drugtopics/252010/674982/article. pdf)
17. OFDT. Estimation du nombre de personnes recevant un traitement de substitution (Subutex 8 mg, Méthadone 60 mg) depuis 1995. Séries Statistiques.
18. Afssaps (Agence Françlaise de Sécurité Sanitaire des Produits de Santé).Recommandations de bonnes pratiques 2009. Douleur rebelle en situation palliative avancée chez l'adulte- Argumentaire. . afssaps.fr/content/download/26391/348792/version/2/file/ RBP-palliatifs- argumentaire.pdf
19. Gerada C, Ashworth M. ABC of mental health Addiction and dependence-I: Illicit drugs. BMJ 1997; 315: 297-300
20. Cicero T, Surratt H, Inciardi J, et al. Relationship between therapeutic use and abuse of opioid analgesic in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf 2007; 16: 827-40